May 14, 2020 / 11:39 AM / 24 days ago

BRIEF-Inmed Pharmaceuticals Reports Qtrly Loss Per Share $0.02

May 14 (Reuters) - InMed Pharmaceuticals Inc:

* INMED PHARMACEUTICALS REPORTS THIRD QUARTER FISCAL 2020 FINANCIAL RESULTS AND PROVIDES RESEARCH AND DEVELOPMENT AND BUSINESS UPDATE

* INMED PHARMACEUTICALS - QTRLY LOSS PER SHARE $0.02

* INMED PHARMACEUTICALS - AT MARCH 31, 2020, CO’S CASH, EQUIVALENTS & SHORT-TERM INVESTMENTS WERE $9.94 MILLION

* INMED PHARMACEUTICALS - FINAL RESULTS FROM 755-101-HV TRIAL ANTICIPATED IN Q3 OF CALENDAR 2020

* INMED PHARMACEUTICALS - CONTINUES TO ANTICIPATE COMMENCEMENT OF IND-ENABLING PRECLINICAL TOXICOLOGY STUDIES IN H2 OF CALENDAR 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below